Table 2.
Pharmacokinetic parameters of LBL-007 antibody levels in monkeys.
t1/2 |
C5min |
AUClast |
AUC0-∞ |
V |
CL |
MRTlast |
||
---|---|---|---|---|---|---|---|---|
dose (mg/kg) |
(h) | (µg/mL) | (h*µg/mL) | (h*µg/mL) | (mL/kg) | (mL/h/kg) | (h) | |
3 | Mean | 275.31 | 73.22 | 9013.81 | 11364.48 | 109.27 | 0.27 | 229.32 |
SD | 13.87 | 17.27 | 2327.64 | 2970.21 | 33.84 | 0.07 | 5.17 | |
10 | Mean | 335.31 | 194.4 | 26601.72 | 34144.9 | 148.28 | 0.31 | 224.5 |
SD | 36.9 | 53.34 | 9867.22 | 12139.57 | 37.13 | 0.11 | 5.52 | |
30 | Mean | 193.52 | 616.15 | 63570.08 | 69937.95 | 119.44 | 0.43 | 203.43 |
SD | 31.95 | 122.23 | 934.48 | 3042.52 | 14.57 | 0.02 | 2.54 |
Pharmacokinetic parameters were calculated using a non-compartmental analysis. T1/2, half-life; C5min, concentration of 5 min; AUC, The area under the concentration versus time curve; V, apparent volume of distribution; CL, clearance; MRT, Mean Residence Time.